These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8738024)

  • 21. Quantification of phenylbutazone in equine sera by use of high-performance liquid chromatography with a nonevaporative extraction technique.
    Peck KE; Ray AC; Manuel G; Rao MM; Foos J
    Am J Vet Res; 1996 Nov; 57(11):1522-4. PubMed ID: 8915422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of phenylbutazone and its metabolites by high performance liquid chromatography.
    Taylor JB; Lees P; Gerring EL
    Equine Vet J; 1981 Jul; 13(3):201-3. PubMed ID: 7297550
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.
    Finocchio EJ; Ozog FJ; Oehme FW; Johnson JH; Osbaldiston GW
    J Am Vet Med Assoc; 1970 Feb; 156(4):454-6. PubMed ID: 5414171
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
    Simmons BR; Jagota NK; Stewart JT
    J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems.
    Woods WE; Weckman T; Blake JW; Tobin T
    J Pharmacol Methods; 1986 Dec; 16(4):297-313. PubMed ID: 3784574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of desipramine on intestinal absorption of phenylbutazone and other drugs.
    Consolo S; Garattini S
    Eur J Pharmacol; 1969; 6(3):322-6. PubMed ID: 5799193
    [No Abstract]   [Full Text] [Related]  

  • 32. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of non-steroidal anti-inflammatory drugs residues in animal muscles by liquid chromatography-tandem mass spectrometry.
    Jedziniak P; Szprengier-Juszkiewicz T; Olejnik M; Zmudzki J
    Anal Chim Acta; 2010 Jul; 672(1-2):85-92. PubMed ID: 20579495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPLC method for the determination of 4-hydroxyphenylbutazone in phenylbutazone.
    Bulcsu H; Sándor G
    Acta Pharm Hung; 1980 Jul; 50(4):173-6. PubMed ID: 7270184
    [No Abstract]   [Full Text] [Related]  

  • 35. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.
    Husain S; Kifayatullah M; Rao RN
    J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.